The effects of Transcranial Magnetic Stimulation, or TMS, on those suffering from depression is well documented by the mental health community and TMS Health Solutions. TMS treatment for those dealing with mildly resistant depression was approved by the FDA in 2008. While there is never a guarantee of remission, TMS Health Solutions has had great success treating patients with clinical depression in the Northern California area. As time passes, the applications for TMS are expanding, and researchers from around the world are working to discover what else TMS Health Solutions can do. Here are some of the groundbreaking applications for this cutting-edge technology.
TMS for Memory Disorders
TMS Health Solutions has recently started using TMS to treat mild cognitive impairment and dementia. While not cleared for such use by the FDA, European regulatory agencies have approved TMS for the treatment of Alzheimer’s disease and dementia. TMS Health Solutions offers its services to individuals with mild cognitive impairment, an intermediary stage between normal aging and mild dementia. TMS Health Solutions treats those who have experienced memory loss issues but can still conduct normal day-to-day activities. People diagnosed with mild cognitive impairment are under a substantial risk of their disorder progressing to mild dementia. But TMS might be able to decrease this risk.
TMS for Weight Loss
Despite a lack of FDA approval, bold researchers are discovering that TMS can help obese people lose weight by altering the composition of their intestinal bacteria (also known as gut microbiota). Researchers at IRCCS Policlinico San Donato and the University of Milan in Milan, Italy, have studied whether TMS could improve the gut microbiota composition. Scientists know that impaired gut microbiota can alter the brain’s chemistry for appetite and fullness, but they wondered whether the brain’s signals affect a person’s gut microbiota. The study in Milan showed that after five weeks, subjects treated with TMS had increased levels of several beneficial bacterial species. These subjects were able to lose 3% of their body fat.
TMS for ADHD
ADHD is a common neuropsychiatric disorder that affects adults and children. The disorder can have major negative effects that impact one’s social, educational, and occupational functioning. Our current understanding of the disorder suggests that certain circuit abnormalities, mostly in the right hemisphere, are responsible for most of the irregularities in sensory integration, and dopamine appears to be the main neurochemical alteration causing these irregularities. As TMS has been proven to directly affect dopamine levels, many consider it a promising therapy for ADHD.
TMS for PTSD
Roughly eight percent of Americans will experience Post-Traumatic Stress Disorder at some point in their lives. But recent studies have suggested that TMS can have positive treatment outcomes for patients suffering from PTSD. One study conducted at Eastern Virginia Medical School combined TMS with talk therapy to combat PTSD. Veterans affected by PTSD were asked to talk about traumatic wartime events. At the same time, TMS machines targeted the dorsolateral prefrontal cortex of their brains. After 10 sessions, each lasting an hour and a half, 70 percent of participants no longer met the criteria for PTSD. While the military has shown an increased interest in TMS treatment, much research is still needed to hone in on TMS treatment for PTSD.
TMS for Migraines
Spring TMS by eNeuro was cleared by the FDA in 2014. The technology has shown great success in thwarting and lessening migraines when administered right before a migraine starts. Using a hand-held unit that people can buy or rent, migraine sufferers are bringing TMS use into the home. And Spring TMS is being used for migraine prevention, not just treatment. The FDA granted prevention indication in 2017. Researchers recently studied 267 people who suffered from migraines with aura. More than 33 percent of those who used TMS were pain-free after a couple hours, compared to 22 percent who didn’t receive TMS treatment.